Skip to main content

Advertisement

Log in

Diagnostic efficiency of Sestamibi gammagraphy and Doppler sonography in the preoperative assessment of breast lesions

  • Research Articles
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Introduction

It would be desirable to have preoperative methods that allow an adequate selection of patients with breast lesions to rule out breast cancer: The aim of the present study is to evaluate the efficiency of preoperative Sestamibi gammagraphy and Doppler sonography regarding the differential diagnosis of malignancy in breast lesions.

Material and methods

A prospective observational study was conducted on 88 consecutive patients with breast lesions. All the patients underwent preoperative Doppler sonogrpahy with an echo-enhancing agent and Sestamibi gammagraphy. All the patients had histopathological study of the surgical specimen to compare with the result of the preoperative techniques. These comparations were done both for the overall series and separately for palpable and non-palpable lesions.

Results

In the overall series results, both tests separately and the two combined, are related significantly to the malignant histological diagnosis (p<0.001). In palpable lesions, there is a considerable increase in sensitivity, and especially in specificity, attaining 100%, with the combination of both tests. In non-palpable lesions, a relationship was only found between the results of the Sestamibi gammagraphy and the malignant histological diagnosis (93.3%; p<0.05).

Conclusions

Sestamibi gammagraphy and Doppler sonography are two efficient exploratory techniques in the preoperative assessment of malignancy in breast lesions, especially for palpable lesions, and this efficiency is greater when they are combined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Waxman AD. The role of 99mTc-methoxyiso butylisonitrile in imaging breast cancer. Sem Nucl Med. 1997;27:40–54.

    Article  CAS  Google Scholar 

  2. Kopans DB. The positive predictive value of mammography. Am J Roentgenol. 1992; 158:521–6.

    CAS  Google Scholar 

  3. Bombardieri E, Crippa F, Maffioli G, Greco M. Nuclear Medicine techniques for the study of breast cancer. Eur J Nucl Med. 1997;24:809–24.

    PubMed  CAS  Google Scholar 

  4. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg. 1994;178:491–7.

    PubMed  CAS  Google Scholar 

  5. Palmedo H, Grünwald F, Bender H, et al. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med. 1996;23:940–6.

    Article  PubMed  CAS  Google Scholar 

  6. Koukouraki S, Koukouraki MI, Vagios E, Velidaki A, Tsiftsis D, Karkavitsas N. The role of 99mTc-sestamibi scintimammography and colour Doppler ultrasonography in the evaluation of breast lesions. Nucl Med Commun. 2001;22:1245–8.

    Article  Google Scholar 

  7. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperrier J. Technetium 99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med. 1995;56:1758–65.

    Google Scholar 

  8. Raza S, Baum JK. Solid breast lesions: evaluation with power Doppler ultrasound. Radiology. 1997;205:164–8.

    Google Scholar 

  9. Özdemir A, Özdemir H, Maral I, Konus Ö, Yücel S, Isik S. Differential diagnosis of solid breast lesions: contribution of Doppler studies to mammography and gray scale imagines. J Ultrasound Med. 2001;20:1091–101.

    PubMed  Google Scholar 

  10. Jackson VP. The current role of ultrasonography in breast imaging. Radiol Clin North Am. 1995;55:1161–70.

    Google Scholar 

  11. Milz P, Lienemann A, Kessler M, Reiser M. Evaluation of breast lesions by power Doppler sonography. Eur Radiol. 2001;11: 547–54.

    Article  PubMed  CAS  Google Scholar 

  12. Piñero A, Reus M, Illana J, et al. Palpable breast lesions: utility of Doppler sonography for diagnosis of malignancy. Breast. 2003;12:258–63.

    Article  PubMed  Google Scholar 

  13. Canby R, Silver S, Pohost G. Relations of the myocardial imaging agents 99m-TcMIBI and 201-T1 to myocardial blood flow in a canine model of myocardial ischemic insult. Circulation. 1990;81:289–96.

    PubMed  CAS  Google Scholar 

  14. Khalkhali I, Mishkin F, Diggles L, Klein SR. Radionuclide-guided sterotatic prebiopsy localization of nonpalpable breast lesions with normal mammograms. J Nucl Med. 1997;58:1019–22.

    Google Scholar 

  15. McHenry CR, Lee K, Saadey J, Neumann DR, Esselstyn CB. Parathyroid localization with technetium 99m sestamibi: a prospective evaluation. J Am Coll Surg. 1996;185:25–30.

    Google Scholar 

  16. O’Doherty MJ, Keetle AG, Wells P, Collins REC, Cookley AJ. Parathyroid imaging with technetium 99 m Sestamibi: preoperative localization and tissue uptake studies. J Nucl Med. 1992;33:313–8.

    PubMed  CAS  Google Scholar 

  17. Lee VS, Wilkinson RH, Leight GS, Coogan AG, Coleman RE. Hyperparathyroidism in high risk surgical patients: evaluation with double-phase technetium 99m sestamibi imaging. Radiology. 1995;197:627–33.

    PubMed  CAS  Google Scholar 

  18. Kim SW, Park SS, Ahn SJ, et al. Identification of angiogenesis in primary breast carcinoma according to the image análisis. Breast Cancer Res Treat 2002;74:121–9.

    Article  PubMed  CAS  Google Scholar 

  19. Chiu M, Krounage J, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts. J Nucl Med. 1990;51:1646–53.

    Google Scholar 

  20. Piñero A, Rodríguez JM, Ortiz, S, et al. Estudio del contenido mitocondrial en adenomas paratiroideos y su correlación con la gammagrafia con Tc99m-Sestamibi. Cirugia Española. 1999;66:285–8.

    Google Scholar 

  21. Cutrone JA, Yospur LS, Khalkhali I, et al. Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions. J Nucl Med. 1998; 39:449–53.

    PubMed  CAS  Google Scholar 

  22. Bonazzi G, Cistaro A, Belló M, et al. Breast cancer cellular proliferation indexes and 99mTc sestamibi capture: What correlation? J Exp Clin Cancer Res. 2001; 20:91–4.

    PubMed  CAS  Google Scholar 

  23. Piñero A, Rodríguez JM, Martínez-Barba E, Canteras M, Sitges-Serra A, Parrilla P. Tc99m-sestamibi scintigraphy and cell proliferation in primary hyperparathyroidism: a causal or casual relationship? Surgery 2003;134:41–4.

    Article  PubMed  Google Scholar 

  24. Piwnica-Worms D, Chiu M, Budding M, Krounage JF, Kramer RA, Croup JM. Functional imaging of multidrug resistant p-glycoprotein with an organotechnetium complex. Cancer Res. 1993;53:977–84.

    PubMed  CAS  Google Scholar 

  25. Del Vecchio S, Ciarmiello A, Potena M, et al.In vivo detection of multidrug resistant (MDR1) phenotype by technetium 99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med. 1997;24:150–9.

    Article  PubMed  CAS  Google Scholar 

  26. Del Vecchio S, Ciarmiello A, Pace L, et al. Fractional retention of technetium 99 m sestamibi as an index of p glycoprotein expression in untreated breast cancer patients. J Nucl Med. 1997;38:1348–51.

    PubMed  Google Scholar 

  27. Burak Z, Argon M, Memi S. Evaluation of palpable breast masses with Tc99m MI-BI: a comparative study with mammography and ultrasonography. Nucl Med Commun. 1994;15:604–12.

    PubMed  CAS  Google Scholar 

  28. Kao C, Wang S, Liu T. The use of Tc99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med. 1994;21:432–6.

    PubMed  CAS  Google Scholar 

  29. Lam W, Yang W, Chan Y, Stewart IE, Metreweli C, King W. Detection of axillary lymph node metastases in breast carcinoma by technetium 99m sestamibi scintigrphy, ultrasound and conventional mammography. Eur J Nucl Med. 1996;23:498–503.

    Article  PubMed  CAS  Google Scholar 

  30. Clifford E, Lugo-Zambudio C, Kao C. Tc99m MIBI uptake in breast carcinoma and axillary lymph node metastases. Am J Surg. 1996;172:483–6.

    Article  PubMed  CAS  Google Scholar 

  31. Howarth D, Sillar R, Clark D, Lan L. Technetium-99m sestamibi scintimammography: the influence of histopathological characteristics, lesion size and the presence of carcinomain situ in the detection of breast carcinoma. Eur J Nucl Med. 1999;26:1475–81.

    Article  PubMed  CAS  Google Scholar 

  32. Wang HC, Sun SS, Kao A, Lin CC, Lee CC. Comparison of technetium-99m methoxyisobutylisonitrile scintimammography and ultrasonography in the diagnosis of breast cancer in patients with mammographically dense breast. Cancer Invest. 2002;20:318–25.

    Article  PubMed  Google Scholar 

  33. Liberman M, Sampalis F, Mulder DS, Sampalis JS. Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature. Breast Cancer Res Treat. 2003;80:115–26.

    Article  PubMed  CAS  Google Scholar 

  34. Waxman A, Nagaraj N, Ashok G. Sensitivity and especifity of 99mTc methoxyi-sobutylisonitrile (MIBI) in the evaluation of primary carcinoma of the breast: comparison of palpable and nonpal-pable lesions with mammography (abstract). J Nucl Med. 1994;35:22.

    Google Scholar 

  35. Villanueva-Meyer J, Leonard M, Briscoe E, et al. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med. 1996;37:926–30.

    PubMed  CAS  Google Scholar 

  36. Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions. J Nucl Med. 1998;39:86–91.

    PubMed  CAS  Google Scholar 

  37. Folkman J. Angiogenesis and tumor growth. N Eng J Med. 1996;334:921–8.

    Google Scholar 

  38. Watermann D, Madjar H, Sauerbrei W, Hirt V, Prompeler H, Stickeler E. Assessment of breast cancer vascularisation by Doppler ultrasound as a prognostic factor of survival. Oncol Rep. 2004;11:905–10.

    PubMed  Google Scholar 

  39. Madjar H, Prompeler HJ, Del Favero C, Hackelöer BJ, Lull JB. A new Doppler signal enhancing agent for flow assessment in breast lesions. Eur J Ultrasound. 2000;12:123–30.

    Article  PubMed  CAS  Google Scholar 

  40. Madjar H, Sauerbrei W, Prömpeler HJ, Wolfarth R, Gufler H. Color Doppler and duplex flow analisis for classification of breast lesions. Gynecol Oncol. 1997;64:392–403.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Piñero.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piñero, A., Galindo, P.J., Illana, J. et al. Diagnostic efficiency of Sestamibi gammagraphy and Doppler sonography in the preoperative assessment of breast lesions. Clin Transl Oncol 8, 103–107 (2006). https://doi.org/10.1007/s12094-006-0166-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-006-0166-x

Key words

Navigation